Published in J Proteome Res on December 12, 2005
Targeted quantitative analysis of Streptococcus pyogenes virulence factors by multiple reaction monitoring. Mol Cell Proteomics (2008) 3.29
Automated selected reaction monitoring software for accurate label-free protein quantification. J Proteome Res (2012) 0.99
Regulation of expression of the Haemophilus ducreyi LspB and LspA2 proteins by CpxR. Infect Immun (2009) 0.98
Human serum induces streptococcal c5a peptidase expression. Infect Immun (2009) 0.83
The Streptococcus pyogenes proteome: maps, virulence factors and vaccine candidates. Future Microbiol (2010) 0.81
Differential secretomics of Streptococcus pyogenes reveals a novel peroxide regulator (PerR)-regulated extracellular virulence factor mitogen factor 3 (MF3). Mol Cell Proteomics (2011) 0.80
Plasma exposure alters the proteome of S. pyogenes. J Proteome Res (2005) 0.75
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A (2007) 7.50
mzML--a community standard for mass spectrometry data. Mol Cell Proteomics (2010) 4.81
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl (2007) 3.41
Targeted quantitative analysis of Streptococcus pyogenes virulence factors by multiple reaction monitoring. Mol Cell Proteomics (2008) 3.29
IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J (2002) 2.77
M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell (2004) 2.46
Antibody orientation at bacterial surfaces is related to invasive infection. J Exp Med (2012) 2.30
Methods for the detection and analysis of protein-protein interactions. Proteomics (2007) 2.29
Heparin-binding protein: a diagnostic marker of acute bacterial meningitis. Crit Care Med (2011) 2.29
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol (2002) 2.21
The evolution of the protein corona around nanoparticles: a test study. ACS Nano (2011) 2.05
Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis (2009) 1.94
Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J Immunol (2002) 1.87
MtsABC is important for manganese and iron transport, oxidative stress resistance, and virulence of Streptococcus pyogenes. Infect Immun (2003) 1.82
The proteios software environment: an extensible multiuser platform for management and analysis of proteomics data. J Proteome Res (2009) 1.76
TraML--a standard format for exchange of selected reaction monitoring transition lists. Mol Cell Proteomics (2011) 1.65
Genome-based identification and analysis of collagen-related structural motifs in bacterial and viral proteins. J Biol Chem (2003) 1.65
SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem (2003) 1.60
Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A (2004) 1.51
Antimicrobial activities of heparin-binding peptides. Eur J Biochem (2004) 1.46
The human protease inhibitor cystatin C is an activating cofactor for the streptococcal cysteine protease IdeS. Chem Biol (2008) 1.45
Proteomic analysis and discovery using affinity proteomics and mass spectrometry. Mol Cell Proteomics (2011) 1.44
Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochemistry (2004) 1.43
Modular, scriptable and automated analysis tools for high-throughput peptide mass fingerprinting. Bioinformatics (2004) 1.38
The contact system--a novel branch of innate immunity generating antibacterial peptides. EMBO J (2006) 1.36
Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol (2006) 1.36
The regulator PerR is involved in oxidative stress response and iron homeostasis and is necessary for full virulence of Streptococcus pyogenes. Infect Immun (2002) 1.33
Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. Proc Natl Acad Sci U S A (2004) 1.32
The HUPO proteomics standards initiative- mass spectrometry controlled vocabulary. Database (Oxford) (2013) 1.31
Streptococcus pyogenes expressing M and M-like surface proteins are phagocytosed but survive inside human neutrophils. Cell Microbiol (2003) 1.29
IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc Natl Acad Sci U S A (2008) 1.27
Proteolysis and its regulation at the surface of Streptococcus pyogenes. Mol Microbiol (2002) 1.25
alpha2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J Biol Chem (2004) 1.23
140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry. J Proteome Res (2006) 1.21
Nanopipette delivery of individual molecules to cellular compartments for single-molecule fluorescence tracking. Biophys J (2007) 1.20
Assertive outreach teams in London: models of operation. Pan-London Assertive Outreach Study, part 1. Br J Psychiatry (2003) 1.18
Blocking of experimental arthritis by cleavage of IgG antibodies in vivo. Arthritis Rheum (2007) 1.17
Rural to urban migration and changes in cardiovascular risk factors in Tanzania: a prospective cohort study. BMC Public Health (2010) 1.16
Crystal structure and biological implications of a bacterial albumin binding module in complex with human serum albumin. J Biol Chem (2004) 1.14
Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease. J Infect Dis (2004) 1.14
Interactions with fibronectin attenuate the virulence of Streptococcus pyogenes. EMBO J (2004) 1.12
Large-scale proteomics analysis of human ovarian cancer for biomarkers. J Proteome Res (2007) 1.12
Caring for carers of people with stroke: developing a complex intervention following the Medical Research Council framework. Clin Rehabil (2005) 1.11
IdeS: a bacterial proteolytic enzyme with therapeutic potential. PLoS One (2008) 1.10
Binding of calcium ions and SNAP-25 to the hexa EF-hand protein secretagogin. Biochem J (2007) 1.09
IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes. Curr Opin Microbiol (2003) 1.09
Identification of two protein-binding and functional regions of curli, a surface organelle and virulence determinant of Escherichia coli. J Biol Chem (2002) 1.09
Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood (2002) 1.09
Predictors of quality of life in ulcerative colitis: the importance of symptoms and illness representations. Inflamm Bowel Dis (2005) 1.08
Quantitative proteomics targeting classes of motif-containing peptides using immunoaffinity-based mass spectrometry. Mol Cell Proteomics (2012) 1.07
Streptococcus pyogenes bacteria modulate membrane traffic in human neutrophils and selectively inhibit azurophilic granule fusion with phagosomes. Cell Microbiol (2006) 1.06
The dual role of the contact system in bacterial infectious disease. Thromb Haemost (2007) 1.05
SpeB modulates fibronectin-dependent internalization of Streptococcus pyogenes by efficient proteolysis of cell-wall-anchored protein F1. Microbiology (2004) 1.04
Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid. Mol Immunol (2007) 1.04
Metabolomic and proteomic analysis of a clonal insulin-producing beta-cell line (INS-1 832/13). J Proteome Res (2007) 1.03
Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth. Microb Pathog (2003) 1.02
Biomarker discovery: a proteomic approach for brain cancer profiling. Cancer Sci (2007) 1.01
Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes. Nephrol Dial Transplant (2010) 1.00
Protein expression changes in ovarian cancer during the transition from benign to malignant. J Proteome Res (2012) 1.00
Plasma lipid composition and risk of developing cardiovascular disease. PLoS One (2013) 0.99
Quantitative proteomics and transcriptomics of potato in response to Phytophthora infestans in compatible and incompatible interactions. BMC Genomics (2014) 0.99
Structure, specificity, and mode of interaction for bacterial albumin-binding modules. J Biol Chem (2001) 0.99
Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation. Mol Microbiol (2007) 0.99
Automated selected reaction monitoring software for accurate label-free protein quantification. J Proteome Res (2012) 0.99
Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response. PLoS Pathog (2008) 0.98
Peptidoglycan from Staphylococcus aureus induces tissue factor expression and procoagulant activity in human monocytes. Infect Immun (2002) 0.98
Diagnosis of type 2 diabetes at an older age: effect on mortality in men and women. Diabetes Care (2004) 0.98
Characterization of the lipid droplet proteome of a clonal insulin-producing β-cell line (INS-1 832/13). J Proteome Res (2012) 0.97
Wavelet-based method for noise characterization and rejection in high-performance liquid chromatography coupled to mass spectrometry. Anal Chem (2008) 0.96
Data processing methods and quality control strategies for label-free LC-MS protein quantification. Biochim Biophys Acta (2013) 0.95
Paranoid potato: phytophthora-resistant genotype shows constitutively activated defense. Plant Signal Behav (2012) 0.94
Histidine-rich glycoprotein promotes bacterial entrapment in clots and decreases mortality in a mouse model of sepsis. Blood (2010) 0.93
Analysis of macular thickness in British population using optical coherence tomography (OCT): an emphasis on interocular symmetry. Curr Eye Res (2008) 0.93
Treatment of invasive streptococcal infection with a peptide derived from human high-molecular weight kininogen. Blood (2009) 0.93
IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection. Infect Immun (2006) 0.93
Multisite phosphorylation of adipocyte and hepatocyte phosphodiesterase 3B. Biochim Biophys Acta (2007) 0.93
Proteome analysis of the xylose-fermenting mutant yeast strain TMB 3400. Yeast (2009) 0.92
An adaptive alignment algorithm for quality-controlled label-free LC-MS. Mol Cell Proteomics (2013) 0.92
Cleavage of IgG1 and IgG3 by gingipain K from Porphyromonas gingivalis may compromise host defense in progressive periodontitis. FASEB J (2011) 0.91
Streptococcus pyogenes and phagocytic killing. Nat Med (2002) 0.91
Automated methods for improved protein identification by peptide mass fingerprinting. Proteomics (2004) 0.91
Automated reporting from gel-based proteomics experiments using the open source Proteios database application. Proteomics (2007) 0.90
Streptococcus pyogenes in human plasma: adaptive mechanisms analyzed by mass spectrometry-based proteomics. J Biol Chem (2011) 0.90
Strategy for surveying the proteome using affinity proteomics and mass spectrometry. Proteomics (2009) 0.90
Somatostatin effects on the proteome of the LNCaP cell-line. Int J Oncol (2007) 0.90
Tracking diffusion of GM1 gangliosides and zona pellucida binding molecules in sperm plasma membranes following cholesterol efflux. Dev Biol (2010) 0.89
Identification of a novel host-specific IgM protease in Streptococcus suis. J Bacteriol (2012) 0.89
Specific in vivo deletion of B-cell subpopulations expressing human immunoglobulins by the B-cell superantigen protein L. Infect Immun (2004) 0.89
Effects of it takes two to talk--the hanen program for parents of preschool children with cerebral palsy: findings from an exploratory study. J Speech Lang Hear Res (2009) 0.89
Generic workflow for quality assessment of quantitative label-free LC-MS analysis. Proteomics (2011) 0.89
c-Jun N-terminal kinase phosphorylation of MARCKSL1 determines actin stability and migration in neurons and in cancer cells. Mol Cell Biol (2012) 0.89
The streptococcal protease IdeS modulates bacterial IgGFc binding and generates 1/2Fc fragments with the ability to prime polymorphonuclear leucocytes. Mol Immunol (2008) 0.88